You enforce a director’s fiduciary duty under Section 305 of the Companies and Allied Matters Act (CAMA) 2020 by initiating legal proceedings in the Federal High Court through a direct action by the company, a derivative action commenced by minority shareholders, or an application for relief against unfairly prejudicial and oppressive conduct under Section 353 of the Act.
Directors stand in a fiduciary relationship towards the company and are bound by law to observe utmost good faith, accountability, and loyalty in all corporate dealings. When a director breaches these duties by diverting corporate opportunities, making undisclosed secret profits, or preferring personal interest over the company’s commercial well-being, CAMA 2020 provides robust legal mechanisms to hold the delinquent officer accountable.
Core Fiduciary Duties Prescribed Under Section 305
Section 305 of CAMA 2020 codifies and expands traditional common law fiduciary duties into strict statutory obligations. Nigerian company law treats directors not merely as corporate agents, but as trustees of the company’s assets and business reputation.
The statute imposes several non-negotiable fiduciary standards:
- Duty of Utmost Good Faith: A director must act in good faith towards the company in transactions with it or on its behalf (Section 305(1)).
- Duty of Single-Minded Loyalty: A director must always act in what the director believes to be the best interests of the company as a whole, preserving its assets and furthering its business goals (Section 305(2)).
- Prohibition of Divided Loyalty: A director shall not put himself in a position where personal interest conflicts with duty, nor make secret profit out of the position without full disclosure and general meeting approval (Section 305(3)).
- No Fetters on Discretion: A director must not restrict the future exercise of discretion or delegate discretion without express authorization (Section 305(6)).
- Protection of Corporate Opportunities: A director cannot usurp business opportunities belonging to the company, even after resigning from office if the resignation was prompted by the desire to exploit the opportunity.
Enforcement Mechanism 1: Direct Action by the Company
Under the established legal doctrine derived from Foss v Harbottle and preserved in Section 341 of CAMA 2020, the company itself is the primary and proper plaintiff to sue for breaches of directors’ duties. The fiduciary duty is owed exclusively to the corporate entity, not to individual shareholders.
When delinquent conduct is identified, the board of directors (excluding the conflicted director) can pass a board resolution instructing legal counsel to file an action against the defaulting director in the Federal High Court. If the board is compromised, shareholders can convene an extraordinary general meeting to pass an ordinary resolution authorizing the company to commence litigation against the director.
Enforcement Mechanism 2: Statutory Derivative Action
Where the wrongdoing directors control the board or hold a majority voting block, they will inevitably refuse to cause the company to sue themselves. To prevent injustice, Sections 343 and 346 of CAMA 2020 grant individual or minority shareholders the statutory right to bring a derivative action in the name and on behalf of the company.
Bringing a derivative action requires strict adherence to procedural conditions precedent under Section 346:
- Application for Leave of Court: The intending applicant must apply by originating summons or motion for leave of the Federal High Court to commence the action.
- Notice to the Board: The applicant must establish that reasonable notice was given to the directors of the company, demanding that they initiate legal proceedings, and the directors refused or neglected to do so.
- Proof of Good Faith: The applicant must demonstrate that the application is made in good faith and that bringing the action is in the best interests of the company.
- Substantive Case: The applicant must present a prima facie case showing an actionable breach of fiduciary duty resulting in financial loss or asset diversion.
Enforcement Mechanism 3: Relief Against Oppressive Conduct Under Section 353
When the breach of fiduciary duty forms part of a continuous pattern of mismanagement that unfairly prejudices minority shareholders, an aggrieved member can petition the Federal High Court under Section 353 of CAMA 2020.
This remedy is particularly effective when directors use their fiduciary control to siphon funds, award unmerited management fees to their personal firms, or deliberately suppress dividend declarations to force minority members out of the business.
Remedies Available in the Federal High Court
Upon proving a breach of Section 305, the Federal High Court possesses wide statutory powers to grant effective legal and equitable remedies:
- Injunction: Restraining the director from continuing the unauthorized act or dissipating diverted corporate assets.
- Account of Profits: Compelling the director to disgorge all secret gains, kickbacks, or profits realized from unauthorized transactions.
- Rescission of Contracts: Setting aside self-dealing contracts entered into between the company and the director without proper board disclosure.
- Damages and Restitution: Ordering the director to pay monetary compensation for losses suffered by the company due to negligence or misconduct.
- Constructive Trust: Declaring that assets purchased with company funds or acquired through misappropriated corporate opportunities are held in trust for the company.
- Disqualification and Removal: Removing the director from office and disqualifying the individual from acting as a corporate director for a designated statutory period.
Practical Steps for Gathering Admissible Corporate Evidence
Litigation under Section 305 requires meticulous documentation. Aggrieved parties should obtain certified copies of the company’s CAC Status Report, audited financial statements, board minutes, and bank statements showing unauthorized disbursements. Under Section 347 of CAMA 2020, the court may also order the company to bear the interim costs of a derivative action, shielding the minority shareholder from excessive financial exposure during trial.